Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78,411,033
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
57,907,511
-
Shares change
-
+1,349,304
-
Total reported value, excl. options
-
$193,998,567
-
Value change
-
+$4,533,749
-
Put/Call ratio
-
14033%
-
Number of buys
-
52
-
Number of sells
-
-39
-
Price
-
$3.35
Significant Holders of Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) as of Q3 2024
120 filings reported holding AVIR - Atea Pharmaceuticals, Inc. - COMMON STOCK as of Q3 2024.
Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57,907,511 shares
of 78,411,033 outstanding shares and own 74% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (8,990,734 shares), BML Capital Management, LLC (6,650,000 shares), FMR LLC (6,618,297 shares), EcoR1 Capital, LLC (5,441,896 shares), VANGUARD GROUP INC (4,851,218 shares), TANG CAPITAL MANAGEMENT LLC (4,607,060 shares), Bain Capital Life Sciences Investors, LLC (2,485,638 shares), GEODE CAPITAL MANAGEMENT, LLC (1,924,773 shares), STATE STREET CORP (1,733,486 shares), and Almitas Capital LLC (1,384,529 shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.